Annual General Meeting

INFORMATION IN ACCORDANCE WITH TABLE 8 OF THE REGULATION (EU) 2018/1212

CORPORATE NEWS AGM 2024

CORPORATE NEWS AGM 2024

REMUNERATION REPORT 2023

STATEMENT ON THE COUNTERMOTION THEMIS BETEILIGUNGS-AKTIENGESELLSCHAFT

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG (GERMAN)

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2024 (GERMAN)

INFORMATION PURSUANT TO TABLE 3 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212 (GERMAN)

COUNTERMOTION THEMIS BETEILIGUNGS-AKTIENGESELLSCHAFT

ANNUAL REPORT 2023

REPORT OF THE SUPERVISORY BOARD FOR THE 2023 FINANCIAL YEAR (GERMAN)

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

ANNUAL FINANCIAL STATEMENTS 2023

06/27/2024

PRESENTATION AGM 2024 (German)

 

 

28.06.2024

DIVIDEND ANNOUNCEMENT (GERMAN)

28.06.2024

VOTING RESULTS AGM 2024 (GERMAN)

 

20230614 CN DERMAPHARM AGM 2023

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

DERMAPHARM ANNUAL FINANCIAL STATEMENT 2022

DERMAPHARM ANNUAL REPORT 2022

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2023 (GERMAN)

INFORMATION PURSUANT TO TABLE 3 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212 (GERMAN)

INFORMATION PURSUANT TO TABLE 8 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG (GERMAN)

RENUMERATION REPORT 2022

REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023 (GERMAN)

06/14/2023

PRESENCE AGM 2023

 

 

06/14/2023

VOTING RESULTS AGM 2023

06/16/2023

AGM 2023 DIVIDEND ANNOUNCEMENT

INFORMATION PURSUANT TO TABLE 8 OF THE ANNEX TO IMPLEMENTING REGULATION (EU) 2018/1212

DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2021

INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2021

DERMAPHARM HOLDING SE - INDIVIDUAL FINANCIAL STATEMENT 2021 ACCORDING TO GERMAN COMMERCIAL CODE (HGB) INCLUDING THE ADOPTED ANNUAL FINANCIAL STATEMENTS OF DERMAPHARM HOLDING SE (GERMAN)

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG (GERMAN)

REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2021 (GERMAN)

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2021 (GERMAN)

06/01/2022

DERMAPHARM HOLDING SE - AGM 2022 PRESENTATION

 

06/01/2022

VOTING RESULTS OF THE ANNUAL GENERAL MEETING 2022

 

DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2020

INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2020

DERMAPHARM HOLDING SE - INDIVIDUAL FINANCIAL STATEMENT 2020 ACCORDING TO GERMAN COMMERCIAL CODE (HGB) INCLUDING THE ADOPTED ANNUAL FINANCIAL STATEMENTS OF DERMAPHARM HOLDING SE (GERMAN)

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG (GERMAN)

REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2020 (GERMAN)

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2021 (GERMAN)

06/23/2021

DERMAPHARM HOLDING SE – AGM 2021 PRESENTATION

 

06/23/2021

VOTING RESULTS OF THE ANNUAL GENERAL MEETING 2021

 

DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2019

INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2019

DERMAPHARM HOLDING SE - INDIVIDUAL FINANCIAL STATEMENT 2019 ACCORDING TO GERMAN COMMERCIAL CODE (HGB) INCLUDING THE ADOPTED ANNUAL FINANCIAL STATEMENTS OF DERMAPHARM HOLDING SE (GERMAN)

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG (GERMAN)

REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2019 (GERMAN)

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2020 (GERMAN)

06/17/2020

DERMAPHARM HOLDING SE – AGM 2020 PRESENTATION

 

06/17/2020

VOTING RESULTS OF THE ANNUAL GENERAL MEETING 2020

 

DERMAPHARM HOLDING SE ‒ ANNUAL REPORT 2018

INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE COMBINED MANAGEMENT REPORT, THE EXPLANATORY REPORT OF THE MANAGEMENT BOARD ON THE DISCLOSURES PURSUANT TO SECTIONS 289A (1), 315A (1) GERMAN COMMERCIAL CODE (HGB) AND THE REPORT OF THE SUPERVISORY BOARD FOR FINANCIAL YEAR 2018

DERMAPHARM HOLDING SE - INDIVIDUAL FINANCIAL STATEMENT 2018 ACCORDING TO GERMAN COMMERCIAL CODE (HGB) INCLUDING THE ADOPTED ANNUAL FINANCIAL STATEMENTS OF DERMAPHARM HOLDING SE (GERMAN)

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG (GERMAN)

REPORT OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2018

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2019 (GERMAN)

06/26/2018

DERMAPHARM HOLDING SE – AGM 2018 PRESENTATION

 

06/04/2019

VOTING RESULTS OF THE ANNUAL GENERAL MEETING 2019

 

DERMAPHARM HOLDING SE - ANNUAL REPORT 2017 INCLUDING THE CONSOLIDATED FINANCIAL STATEMENTS, THE MANAGEMENT REPORT ON THE GROUP’S SITUATION AND THE REPORT OF THE SUPERVISORY BOARD EACH FOR THE FINANCIAL YEAR 2017

DERMAPHARM HOLDING SE – INDIVIDUAL FINANCIAL STATEMENT ACCORDING TO GERMAN COMMERCIAL CODE (HGB) (GERMAN)

INVITATION INCLUDING THE AGENDA AND THE DISCLOSURES ACCORDING TO § 124A SENTENCE 1 NO. 2 AND 4 AKTG

REPORT OF THE SUPERVISORY BOARD (AS OF MAY 18, 2018)

ARTICLES OF ASSOCIATION OF DERMAPHARM HOLDING SE (GERMAN)

EXPLANATION OF THE SHAREHOLDERS' RIGHTS 2018 (GERMAN)

06/26/2018

DERMAPHARM HOLDING SE – AGM 2018 PRESENTATION

 

DERMAPHARM AGM 2018 – VOTING RESULTS